Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Bangladesh · Delayed Price · Currency is BDT

16.80

-0.10 (-0.59%)

At close: Jul 23, 2026

Silva Pharmaceuticals Financials Overview

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	329.63	383.65	599.66	716.87	778.67	799.25
Revenue Growth	-23.64%	-36.02%	-16.35%	-7.94%	-2.57%	4.71%
Gross Profit	85.44	100.51	161.75	229.29	285.78	312.99
Operating Income	-141.85	-121.01	-48.25	44.78	111.76	142.09
Net Income	-154.19	-132.95	-64.48	33.08	102.26	119.85
Earnings Per Share	-1.13	-0.97	-0.47	0.24	0.75	0.88
EPS Growth	-	-	-	-67.65%	-14.68%	0.92%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Investments	83.8	102.8	127.49	181.37	261.47	270.33
Total Debt	2.45	31.6	52.33	61.86	99.09	42.71
Net Cash (Debt)	81.35	71.21	75.17	119.51	162.38	227.62
Net Cash Growth	-17.81%	-5.27%	-37.10%	-26.40%	-28.67%	17.48%
Net Cash Per Share	0.60	0.52	0.55	0.88	1.19	1.67

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Cash Flow	-10.36	13.56	3.42	70.1	160.85	159.4
Capital Expenditures	-3.57	-7.07	-32.99	-86.81	-177.64	-77.18
Free Cash Flow	-13.93	6.49	-29.57	-16.7	-16.8	82.22
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Gross Margin	25.92%	26.20%	26.97%	31.99%	36.70%	39.16%
Operating Margin	-43.03%	-31.54%	-8.05%	6.25%	14.35%	17.78%
Pretax Margin	-43.01%	-31.17%	-7.75%	7.03%	14.98%	18.94%
Profit Margin	-46.78%	-34.65%	-10.75%	4.61%	13.13%	15.00%
FCF Margin	-4.23%	1.69%	-4.93%	-2.33%	-2.16%	10.29%

Dividends

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Dividend Per Share	0.100	0.100	0.300	0.500
Dividend Per Share Growth	0%	-66.67%	-40.00%	0%
Dividend Yield	0.71%	0.47%	1.28%	2.68%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 27, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
PE Ratio	-	-	-	89.14	32.17	22.44
P/FCF Ratio	-	225.07	-	-	-	32.71
PS Ratio	6.75	3.81	3.26	4.11	4.22	3.36